From: The burden of metastatic disease of the femur on the Medicare system
Year | Men <65 | Women <65 | <65 group | Men 65+ | Women 65+ | 65+ group | Total |
---|---|---|---|---|---|---|---|
2005 | 9 | 6 | 7.11 | 7 | 8 | 7.55 | 7.51 |
2006 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
2007 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
2008 | 8 | 6 | 6.73 | 6 | 6 | 6 | 6.1 |
2009 | 7 | 6 | 6.37 | 6 | 6 | 6 | 6.04 |
2010 | 9 | 6 | 6.88 | 6 | 6 | 6 | 6.12 |
2011 | 6 | 7 | 6.64 | 6 | 6 | 6 | 6.09 |
2012 | 5 | 6 | 5.65 | 7 | 5 | 5.89 | 5.86 |
r2 | 0.35 | 0.03 | 0.61 | 0.19 | 0.85 | 0.78 | 0.81 |
p value | 0.13 | 0.69 | 0.02 | 0.28 | 0.001 | 0.004 | 0.02 |
Co (LCL; UCL) | −0.33 (−0.79; 0.12) | −0.04 (−0.24; 0.17) | −0.15 (−0.27; −0.03 | −0.10 (−0.29; 0.10) | −0.35 (−0.49; −0.20) | −0.23 (−0.36; −0.11) | −0.22 (−0.33; −0.11) |